Thermally stable enzyme composition and method of preparing the same

MYPI1999004234A0Inactive Publication Date: 2000-04-06THE NISSHIN OILLIO GRP LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI1999004234
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
1998-10-06
Filing Date
1999-09-30
Publication Date
2000-04-06
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Enzymes are thermally unstable in aqueous solutions, particularly lipid-decomposing enzymes, which limits their use in high-temperature applications and requires costly freeze-drying for enzyme powder preparation, reducing activity and increasing production costs.

Method used

A thermally stable enzyme composition is achieved by adding a combination of an oil-soluble vitamin and a phospholipid to the enzyme solution, which improves heat stability and allows for efficient enzyme powder preparation using spray drying without significant activity loss.

Benefits of technology

The enzyme composition maintains high activity at elevated temperatures, enabling stable enzyme reactions with substrates having high melting points and efficient enzyme powder production, reducing production costs and improving thermal stability.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

A THERMALLY STABLE ENZYME COMPOSITION CONTAINS AN ENZYME, AND A HEAT STABILIZER INCLUDING A PHOSPHOLIPID AND AN OIL-SOLUBLE VITAMIN. THE ENZYME COMPOSITION CAN BE PREPARED IN THE FORM OF A POWDER BY DRYING AN ENZYME SOLUTION CONTAINING A PHOSPHOLIPID AND AN OIL-SOLUBLE VITAMIN TO OBTAIN AN ENZYME POWDER.
Need to check novelty before this filing date? Find Prior Art

Description

TITLE OF THE INVENTIONTHERMALLY STABLE ENZYME COMPOSITION AND METHOD OFPREPARING THE SAMEBACKGROUND OF THE INVENTIONThe present invention relates to a thermallystable enzyme composition and a method of manufacturingthe same, and more particularly, to an enzymecomposition thermally stable in an aqueous solution anda method of manufacturing the same.An enzyme can effect a catalytic reaction undermilder conditions and exhibits a high substratespecificity, compared with a chemical reaction.Therefore, an enzyme is widely used in the fields offood industry, chemical industry, pharmaceuticalindustry, etc.However, the enzyme is generally unstable.Particularly, the enzyme stability is low in a solution.It should be noted that a thermal denaturation beginsto take place in many lipid-decomposing enzymes ifthese enzymes are exposed to temperatures exceedingabout 35°C, making it difficult to utilize an enzymein a reaction system using a substrate having a highmelting point. Also, since an enzyme is thermallyunstable, a freeze-drying method that is less likelyto be affected thermally is utilized mainly forconcentrating and preparing an enzyme powder. However,the freeze-drying method requires a tremendous facilityinvestment for the mass production, resulting in a highrunning cost such as a utility cost.For improving the thermal stability of the enzymewithin an aqueous solution, it has been proposed to adda stabilizer to the enzyme. For example, it has beenstudied to add an amino acid such as albumin, casein,or sodium glutamate; a reducing agent such as protein,mercapto ethanol, or cysteine; a polyol such asglycerol, sucrose, or sorbitol; or a water-soluble highmolecular weight substance such as dextran to an enzymesolution. Also proposed are a method of modifyingan enzyme surface with, for example, an emulsifier oranother amphoteric substance as disclosed in JapanesePatent Disclosure (Kokai) No. 6-113847, a method ofmodifying an enzyme surface with an oil-solublesubstance having an isoprenoid structure as disclosedin Japanese Patent Disclosure No. 6-269285, anda method of stabilizing an enzyme by dissolvinga phospholipid in an alcoholic solvent, followed bymixing the resultant solution with an enzyme andsubsequently drying the mixture (Japanese PatentDisclosure No. 1-27719).However, the lipid-decomposing enzyme obtained bythe conventional methods described above is stable onlyunder temperatures of about 37 to 60°C and, thus, isrelatively unstable under heat, making it relativelydifficult to use the enzyme for an enzyme synthesis,etc. using a substrate having a high melting point.Also, in the method of preparing an enzyme powder bya spraying method, which is a typical drying method,the enzyme is concentrated under heat and, then, dried *within a hot gaseous stream. Therefore, the enzymeactivity is lowered.BRIEF SUMMARY OF THE INVENTIONAn object of the present invention is to providea thermally stable enzyme composition exhibitingan improved heat resistance even within an aqueoussolution and capable of stably performing an enzymereaction under high temperatures.Another object is to provide a method of preparingan enzyme composition that permits stably preparingan enzyme powder while preventing the enzyme activityfrom being lowered by the heat in the enzyme powderpreparation even by a drying method under heat.These objects can be achieved according tothe present invention by adding a heat stabilizercomprising a combination of an oil-soluble vitaminand a phospholipid to an enzyme solution. The heatstability of the enzyme is significantly improved byiadding a heat stabilizer including an oil-solublevitamin and a phospholipid.Thus, the present invention provides an enzymecomposition comprising an enzyme and a heat stabilizerincluding a phospholipid and an oil-soluble vitamin.The present invention also provides a methodof preparing a thermally stable enzyme, comprisingthe step of drying an enzyme solution containinga phospholipid and an oil-soluble vitamin to obtainan enzyme powder. The drying should preferably beperformed by a spray drying.In a preferred embodiment of the present invention,the enzyme composition of the invention contains 0.01to 200% by weight of a phospholipid and 0.01 to 100% byjiweight of an oil-soluble vitamin, based on the enzymeweight.The enzyme used in the present invention shoulddesirably be a lipid-decomposing enzyme. Also, it isdesirable to use an oil-soluble vitamin selected fromthe group consisting of tocopherol, tocotrienol,retinol, calciferol, phylloquinone, and ubiquinone.DETAILED DESCRIPTION OF THE INVENTIONjThe present invention provides a method ofpreparing an enzyme, in which a phospholipid andan oil-soluble vitamin are added to an enzyme solutionto improve the thermal stability of the enzyme andwhich permits suppressing the deactivation of theienzyme by heat in a powder preparation by a dryingmethod under heating to make it possible to prepare *an enzyme powder. 'The enzyme used in the present invention, which isnot particularly limited, includes preferably alipid-decomposing enzyme, protease, and sugar-decomposing enzyme. It is particularly desirable touse a lipid-decomposing enzyme. In addition to theenzyme formulations available on the market, the enzymecan be used in the present invention in the form ofa microorganism culture solution, a plant extractionliquid and an animal cell extraction liquid. Further,a culture solution, a concentrated extraction liquidand a desalted concentrated solution can also be usedas the enzyme in the present invention.The lipid-decomposing enzyme used in the presentinvention includes lipases, phospholipases, andesterases. The lipases include, for example,lipoprotein lipase, monoacyl glycerolipase, diacylglycerolipase, triacyl glycerolipase, and galactolipaseThe phospholipases include, for example, lysophospholipase, and phospholipases Al, A2, B, C and D.Further, the esterases include, for example, cholineesterase, cholesterol esterase, pectin esterase,rtropine esterase, acetylcholine esterase, acetylesterase, carboxy esterase, and aryl esterase.The sugar-decomposing enzymes used in the presentinvention include, for example, amylase, glucosidase,cellulase, xylanase, dextranase, chitinase, lysozyme,galactosidase, mannosidase, gluconidase, hyarronidaseand pectinlyase.The protease used in the present inventionincludes endopectidases and exopeptidases. Theendopectidases include, for example, acidic proteinase,serine protease, cystine protease, asparagic acidprotease, thiol protease, and carboxy protease. On theother hand, the exopetidases include, for example,dipeptidylamino peptidase and dipeptidylcarboxypeptidase.The microorganisms producing the enzymes used inthe present invention, which are not particularlylimited, can be selected from bacteria, yeasts,filamentous viruses, and actinomycetes, and include,for example, Psudomonas species, Alcaligenes species,Arthrobacter species, Staphylococcus species,Torulopsis species, Escherichia species, Nicotorulaspecies, Propionlbacterum species, Chromobacterumspecies, Xanthomonas species, Lactobacillus species,Clostridium species, Candida species, Geotrichumspecies, Sacchromycopsis species, Nocardia species,Fuzarium species, Aspergillus species, Penicilliumspecies, Mucor species, Rhisopus species, Phycomycesespecies, Puccinia species, Bacillus species andStreptmycese species.A culture medium containing soybean powder,peptone, corn steep liquor, K2HPO4, (NH4)2S04,MgS04'7H20, etc. can be used for growing themicroorganisms given above. It is desirable for theculture medium to contain soybean powder in an amountof 0.1 to 20% by weight, preferably 1.0 to 10% byweight. Peptone should desirably be contained inah amount of 0.1 to 30% by weight, preferably 0.5 to10% by weight. Corn steep liquor should desirablybe contained in an amount of 0.1 to 30% by weight,preferably 0.5 to 10% by weight. K2HPO4 shoulddesirably be contained in an amount of 0.01 to 20% byweight, preferably 0.1 to 5% by weight. (NH4)2S04should desirably be contained in an amount of 0.01to 20% by weight, preferably 0.05 to 5% by weight.Further, MgSC>4'7H20 should desirably be contained inan amount of 0.01 to 20% by weight, preferably 0.05 to5% by weight. Other culture media can also be used,as exemplified in the Examples described herein later.It is desirable to culture the microorganisms underthe culturing temperature of 10 to 40°C, preferably 20to 3 5cC, an air circulation rate of 0.1 to 2.0 WM,preferably 0.1 to 1.5 WM, a stirring rotation speed of100 to 800 rpm, preferably 200 to 400 rpm, and a pH of3.0 to 10.0, preferably 4.0 to 9.5.The method of extracting the enzymes from theculture is not particularly limited in the presentinvention, though it is desirable to remove thebacterial cells by means of centrifugal separation,membrane filtration, etc. in the case of exoenzymes.It is desirable to carry out the centrifugal separationunder a centrifugal force of 200 to 20,000 X g. It isdesirable to carry out the membrane filtration whilecontrolling the pressure at 3.0 kg / m2 or less -by usingan MF membrane or a filter press. In the case ofendoenzymes, it is desirable to disintegrate the cellsby using a homogenizer, a Waring blender, an ultrasonicdisintegrator, a French press, a ball mill, etc. and »to remove the cell residue by centrifugal separation,a membrane filtration, etc. The stirring rotatingspeed of the homogenizer should be 500 to 30,000 rpm,preferably 1,000 to 15,000 rpm. The Waring blendershould be scanned at a rate of 500 to 5,000 rpm,preferably 1,000 to 10,000 rpm, and the stirring shouldbe performed for 0.5 to 10 minutes, preferably 1 to5 minutes. The ultrasonic disintegrator should bescanned at 1 to 50 KHz, preferably 10 to 20 KHz.Further, glass balls having a diameter of about 0.1 to0.5 mm should desirably be used in the ball mill*The phospholipid that is used as a component ofthe heat stabilizer of the invention is not particu-larly limited in the present invention, and includes,for example, a phospholipid derived from plant seeds,a phospholipid derived from animals, and a phospholipidprepared by an enzyme synthesis or a chemical synthesis.The plant seeds include, for example, rapeseeds,safflower seeds, soybean, corn, sesame seeds, and *cotton seeds. The animal-derived phospholipid includes,for example, phospholipids derived from egg yolk andcattle brain. Further, the phospholipid prepared byenzyme synthesis or chemical synthesis, which is notparticularly limited in the present invention, includes,for example, high purity products of PS (phosphatidylserine), PI (phosphatidyl inositol), PA (phosphatidicacid), LPE {lysophosphatidyl ethanolamine), and LPC(lysophosphatidyl choline) that are produced by abase exchange reaction or hydrolytic reaction usingphospholipase or a chemical synthesis. The kinds ofthe phospholipids, which are not particularly limitedin the present invention, include, for example, PC(phosphatidyl choline), PE (phosphatidyl"ethanol), PA,PI, and their lyso forms.The oil-soluble vitamin that is used as anothercomponent of the heat stabilizer, which is notparticularly limited in the present invention, shoulddesirably be a-, jS - , y-tocopherols, tocotrienol,retinol, calciferol, menaquinone, menadione,phylloquinone, ubiquinone and a mixture thereof.For preparing a thermally stable enzymecomposition of the present invention, an aqueoussolution of an object enzyme is prepared, followed byadding a phospholipid and an oil-soluble vitamin tothe aqueous solution for sufficiently mixing thesecomponents in the solution. Then, the enzyme aqueoussolution having the heat stabilizer added thereto can -be concentrated and converted into a powder.An aqueous solution of the enzyme can be preparedby dissolving the dry enzyme powder in water.Alternatively, a supernatant of the enzyme cultureAsolution or the extraction liquid itself can be usedas the enzyme aqueous solution.The enzyme concentration of the aqueous solution,which is not particularly limited in the presentinvention, should desirably be 0.01 to 90% by weight inthe case of using a, supernatant of the culture or theextraction liquid and 0.01 to 90% by weight in the case'of using a dry enzyme powder.To be more specific, in order to modify thesurface of the enzyme with the heat stabilizer of thepresent invention, a phospholipid may be added inan amount of preferably 0.01 to 2 0 0% by weight, morepreferably 1 to 8% by weight, of the enzyme weightto the aqueous solution of the object enzyme whilemaintaining the solution temperature at 0 to 25°C,preferably 0 to and while stirring the solutionwith a homogenizer at 300 to 10,000 rpm for 1 to30 minutes, preferably 1 to 5 minutes. Then, an oil-soluble vitamin may be added in an amount of preferably0.01 to 100% by weight, more preferably 0.01 to 20% byweight, of the enzyme weight, to the solution whilestirring the solution with a homogenizer at a rate of <100 to 8,000 rpm, preferably 1,000 to 6,000 rpm, for 1to 20 minutes, preferably 1 to 5 minutes. The maximumyields of the concentrate and the powder depend on theconcentration and kind of the enzyme, phospholipid andoil-soluble vitamin, making it possible to determineappropriately the concentrations of these componentsfrom within the ranges given above.The enzyme composition of the present inventioncan be concentrated by a suitable concentrating method.For example, the concentration can be achieved by meansof an evaporator, a.flash evaporator, ultrafiltration(UF), membrane concentration, MF membrane concentration,salting-out with inorganic salts, precipitation usinga solvent, adsorption using an ion-exchange celluloseor the like, and hygroscopic method using a hygroscopicgel. Particularly, a UF membrane concentration andconcentration using an evaporator are preferably used.Concerning the module for the UF membrane concentration,it is desirable to use a plain membrane or a hollowfiber membrane having a fraction molecular weight of3,000 to 100,000, preferably 6,000 to 50,000. It isalso desirable to use a polyacrylonitrile material ora polysulfone material for forming the UF membrane.The concentration using an evaporator should desirablybe performed under a heated temperature of 90°C orless and a reduced pressure of 4 0 cmHg or less, moredesirably under a heated temperature of 80°C or less anda reduced pressure of 60 cmHg or less.The enzyme composition of the present inventioncan be converted into a powder satisfactorily by any ofdrying under a reduced pressure, a freeze drying anda spray drying. It is desirable to employ a freezedrying or a spray drying in view, of the activityrecovery of the enzyme. The spray drying is particu-larly desirable if the production efficiency is alsotaken into account. The spray dryer includes, forexample, a nozzle counter current type, a disc countercurrent type, a nozzle parallel flow type, and a discparallel flow type. Preferably, it is desirable to usea disc parallel flow type spray dryer. For operatingthe spray dryer, it is desirable to control therotating speed of the atomizer at 4,000 to 20,000 rpm,the inlet temperature at 100 to 200°C and the outlettemperature at 40 to 100°C.Examples and Comparative Examples will now bedescribed to set forth more clearly the effect of thepresent invention. Of course, the present invention is^not limited by the following Examples.The heat stability and the remaining activityof each of the enzymes obtained in the Examples and sComparative Examples were evaluated by the methodsgiven below:[Heat Stability]Where the enzyme was powdery, an aqueous solutioncontaining 10% by weight of the enzyme was prepared.Where the enzyme was in the form of a liquid, theliquid enzyme was used as it was. Specifically, eachof the aqueous solution and the liquid enzyme was putin a constant temperature bath maintained at 80°C andsampled 10 minutes, 20 minutes and 30 minutes later tomeasure the remaining activity of the enzyme liquid,which was compared with a sample not subjected to theheat treatment.[Remaining Activity]75 milliliters (mL) of olive oil and 225 mL of 2%polyvinyl alcohol were put in a container of ahomogenizer manufactured by Nippon Seiki K,K. andemulsified for 10 minutes under a rotating speed of15,000 rpm while cooling the emulsion to 10°C with ice.Then, 4 mL of a phosphoric acid buffer solution havinga pH 7.0 was added to 5 mL of the resultant oliveoil emulsion and the mixture was put in a test tube.Further, 1 mL of the enzyme liquid was put in the testtube to carry out reaction for 10 minutes at 37°C,followed by stopping the reaction with 2N HCl. Finallythe hydrolyzed free fatty acid was titrated with. 2NNaOH using phenolphthalein as a color developing liquidThe remaining activity was calculated by comparisonwith the titration amount.Example 1:Strains of Alcaligenes species IFO 14130 werecharged in an amount of 30 liters (L) in a fermentingvessel having an inner volume of SOL and cultured for36 hours under the conditions of 25°C and 0.5 WM usingculture medium 1 given below to obtain 25L of afermented liquid. Then, 30% based on the enzyme weightof "BASIS LP-20" (trade name of a water-dispersiblesoybean phospholipid manufactured by Nisshin Oil Mils,containing 25 - 30 wt% of PC, 25 - 30 wt% of PE and10 - 25 wt% of PI) and 10% of "MIXED TOCOPHEROL"(trade name of tocopherol manufactured by Nisshin OilMills) were added to a supernatant liquid prepared bycentrifuging the culture solution for 15 minutes at4,000 X g. The mixture was stirred for 5 minutes by ahomogenizer at 6,000 rpm while maintaining the mixtureat 5°C and, then, dried by a spray drying in which theinlet temperature and the outlet temperature were setat 190°C and 95°C, respectively, to obtain 565g of alipase powder. The thermal stability was measured foreach of the mixed liquid and the obtained powder, withthe results as shown in Table 1. Incidentally, thesupernatant liquid, to which the soybean phospholipidand the mixed tocopherols were not added, and 305g oflipase powder obtained by spray-drying the supernatant 'liquid were used as references.tComparative Example 1:A mixed liquid was obtained as in Example 1 byadding 30% based on the enzyme weight of BASIS LP-20 to25L of a supernatant of the fermented liquid cultured ■as in Example 1. Also, 485g of lipase powder wasobtained by spray-drying the mixed liquid. The thermalstability was measured for each of the mixed liquidand the obtained powder, with the results as shown inTable 1.Comparative Example 2:A mixed liquid was obtained as in Example 1 byadding 10% of MIXED TOCOPHEROL to 25L of a supernatantof the fermented liquid cultured as in Example 1. Also,432g of lipase powder was obtained by spray-drying themixed liquid. The thermal stability was measured foreach of the mixed liquid and the obtained powder, withthe results as shown in Table 1.Example 2:Strains of Penicillium cyclopium ATCC-34613 werecultured in a triangular flask by using a culturemedium 2 given below for 48 hours by a shaking cultureiunder the conditions of 25°C and 250 rpm. Then,bacteria were removed from the culture solution bycompressive filtration, followed by adding 10% basedon the enzyme weight of "BASIS LG-10" (trade name ofa soybean phospholipid manufactured by Nisshin OilMills, containing 10 - 12 wt% of PC, 10 - 12 wt% ofPE and 4-10 wt% of PI) and 5% by weight ofDL-a-tocopherol to the supernatant of the culturesolution as in Example 1 to obtain a mixed liquid.The thermal stability of the mixed liquid was measured,with the result as shown in Table 2.Comparative Example 3:10% by weight of TWEEN 80 and 5% by weight ofDL- a -tocopherol were mixed as in Example 1 witha supernatant of a fermented liquid cultured as inExample 2 to obtain a mixed liquid. The thermalstability of the mixed liquid was measured, with theresult as shown in Table 2.Comparative Example 4:5% by weight of DL-a-tocopherol and 40% by weightof "SY GLYSTER MSW-750" (trade name of monoglyceridemanufactured by Sakamoto Yakuhin Kogyo K.K.) were mixedas in Example 1 with a supernatant of a fermentedliquid cultured as in Example 2 to obtain a mixedliquid. The thermal stability of the mixed liquid wasmeasured, with the result as shown in Table 2.Comparative Example 5:5% by weight of DL-a-tocopherol and 2% by weight tof "DK ESTER FOR" (trade name of a sugar estermanufactured by Dai-ichi Kogyo Seiyaku K.K.) were mixedas in Example 1 with a.supernatant of a fermentedliquid cultured as in Example 2 to obtain a mixedliquid. The thermal.stability of the mixed liquid wasmeasured, with the result as shown in Table 2.Example 3:Strains of Geotrichum candidum ATCC-3461 werecharged in an amount of 30L in a fermenting vesselhaving an inner volume of 50L and cultured for 24 hoursby using culture medium 4 given below under theconditions of 25°C, 1 WM and a stirring rotation speedof 300 rpm. The culture solution was centrifuged for15 minutes at 3500 X g, and the resultant supernatantiwas used as an enzyme liquid. Then, 30% by weightbased on the enzyme weight of "SLP-WATER SOLUBLELECITHIN" manufactured by True Lecithin Kogyo K.K.(having a composition similar to BASIS LP-20) and 10%by weight of a-tocopherol were mixed as in Example 1with the enzyme liquid to obtain a mixed enzyme liquid.A thermal stability test was applied to the mixedenzyme liquid, with the result as shown in Table 3.Example 4:A mixed enzyme liquid was prepared by mixing eggyolk phospholipid and y -tocopherol as in Example 1 withan enzyme liquid prepared as in Example 3. A thermalstability test was applied to the mixed enzyme liquid,with the result as shown in Table 3.Example 5:A mixed enzyme liquid was prepared by mixing cowbrain phospholipid (50% PS) and mixed tocopherols asin Example 1 with an enzyme liquid prepared as inExample 3. A thermal stability test was applied tothe mixed enzyme liquid, with the result as shown inTable 3.Example 6:A mixed enzyme liquid was prepared by mixingrapeseed phospholipid and "LECHINOL" (trade name ofvitamin A oil manufactured by Kanematsu Shokuhin K.K.) -as in Example 1 with an enzyme liquid prepared as inExample 3. A thermal stability test was applied tothe mixed enzyme liquid, with the result as shown inTable 3.Example 7:A mixed.enzyme liquid was prepared by mixing |a soybean-derived "SUN-LECITHIN A-l" (trade name of anenzyme-decomposed lecithin manufactured by Taiyo Kagaku:K. K» , having a composition similar to Basis LP-20) and"DRY VITAMIN D" (trade name of Calciferol manufacturedby Sankyo K.K.) as in Example 1 with an enzyme liquidprepared as in Example 3. A thermal stability test was^applied to the mixed enzyme liquid, with the result asshown in Table 3. ;Example 8:Strains of Aspergillus niger NRRL-33 7 were chargedin an amount of 300L in a fermenting vessel having aninner volume of 500L and cultured for 48 hours by usingculture medium 3 given below under the conditions of25°C, 1 WM and a stirring rotation speed of 300 rpm.The culture solution was filtered by a compressivefiltration to recover 260L of a supernatant havingbacteria removed therefrom. The supernatant wasconcentrated to 30L by a UF membrane module havinga fraction molecular weight of 3000 and made ofa hollow string membrane of polyacrylonitrile series.The concentrated supernatant was diluted with 230L ofcity water, followed by similarly concentrating thedilute supernatant to 35L. Then, 40% by weight based 4on the enzyme weight of "LECITHIN DELUXE" ('trade nameof lecithin manufactured by Nisshin Oil Mills) and 10%by weight based on the enzyme weight of "TOCOPHEROL 85"manufactured by Nisshin Oil Mills were mixed as inExample 1 with the desalted concentrated solution. Themixed concentrated solution was subjected to a spraydrying under the inlet temperature of 195^, the outlettemperature of 95°C, and an evaporation rate of 10 L / hrto obtain 4.5 kg of a lipase powder. The activityrecovery rate of the powder was 75.8%. A thermalstability test was applied to the lipase powder, withthe result as shown in Table 4.Comparative Example 6:A mixed concentrated solution was obtained as inExample 8 and, then, subjected to a freeze-drying for48 hours by using a freeze-dryer under a reducedpressure of 70 cmHg, and heating of the stackedshelving to 40°C to obtain 4.8 kg of a lipase powder.The activity recovery rate of the powder was 72.9%.A thermal stability test was applied to the lipasepowder, with the result as shown in Table 4.LComparative Example 7:A mixed concentrated solution was obtained as inExample 8. Then, acetone cooled to -20°C was addedto the mixed concentrated solution in an amount equalto that of the mixed concentrated solution (1:1).The mixture was kept stirred for 3 hours with a stirrer,followed by subjecting the precipitate to a suctionfiltration by using a filtering paper (type A).The precipitate was recovered and, then, subjected toa vacuum drying under a pressure of 70 cmHg or moreto obtain 2.4 kg of a lipase powder. The activityrecovery rate of the powder was 33.9%. A thermalstability test was applied to the lipase powder, withthe result as shown in Table 4.Example 9:Strains, of Candida sylindracea NRRL Y-1469 werecharged in an amount of 30L in a fermenting vesselhaving an inner volume of SOL and cultured for 24 hoursby using culture medium 4 given below under theconditions of 25°C, 1 WM and a stirring rotation speedof 400 rpm. The culture solution was centrifuged for '15 minutes at 3,000 X g to obtain 25L of a supernatant.The supernatant was concentrated by an evaporatorheated to 80°C under a reduced pressure of 60 cmHg toobtain 3L of a concentrated solution. 40% by weightbased on the enzyme amount and 20% by weight of apowdery vitamin D manufactured by Kanematsu ShokuhinK.K. were mixed as in Example 1 with the concentrated (solution. The mixture was subjected to a spray dryingunder the inlet temperature of 195°C, the outlettemperature of 95°C and an evaporation rate of 10 L / hrto obtain 450g of a lipase powder. A thermal stabilitytest was applied to each of the mixed concentratedsolution and the lipase powder, with the results asshown in Table 5.Example 10:Strains of Streptmycese species IFO 3110 werecharged in an amount of 30L in a fermenting vesselhaving an inner volume of SOL and cultured for 4 8 hours^by using culture medium 5 given below under theconditions of 2 5°C, 1 WM and a stirring rotation speedof 300 rpm. The culture solution was centrifuged for10 minutes at 6,000 X g to obtain 24L of a supernatant.The supernatant was concentrated by an evaporator underheating at 80°C and a reduced pressure of 6 0 cmHg toobtain 3L of a concentrated solution. Then, 10% byweight based on the enzyme weight of Basis LP-20manufactured by Nisshin Oil Mills and 10% by weight ofMIXED TOCOPHEROL were mixed as in Example 1 with theconcentrated solution. The mixed concentrated solutionwas subjected to a spray drying under the inlettemperature of 195°C, the outlet temperature of 95"C andan evaporation rate of 10 L / hr to obtain 480g ofphospholipase powder. A thermal stability test wasapplied to the mixed concentrated solution and to thephospholipase powder, with the results as shown in fTable 5.Example 11:Strains of Xanthomonas campestris NRRL-B1459 werecharged in 10 triangular flasks each having an innervolume of 3L, the charging amount being 1L for eachflask, and cultured for 48 hours at 30°C by using theculture medium 1 under a stirring rotation speed of250 rpm. The culture solution was centrifuged for15 minutes at 6000 rpm to obtain a'supernatant, which1was cooled to 4°C with ice. Then, 4 0% by weight basedon the enzyme amount of "SLP-PC35" (trade name ofsoybean phospholipid manufactured by True LecithinK.K.) and 50% by weight of vitamin AD oil manufacturedby Takeda Yakuhin Kogyo K.K. were mixed with the cooledsupernatant. The mixture was kept stirred with astirrer for 24 hours while cooling the mixture to 4°C ]with ice, followed by subjecting the mixture to a spraydrying under the inlet temperature of 191°C, the outlettemperature of 95°C and a water evaporation rate of5 L / hr to obtain 880g of an esterase powder enzyme.A thermal stability test was applied to each of themixed concentrated solution and the esterase powderenzyme,-with the results as shown in Table 5.Example 12:Each of lipases available on the market, i.e.,LIPASE OF (trade name of lipase manufactured by MeitoSangyo K.K.), LIPASE PL (trade name of lipasemanufactured by Meito Sangyo K.K.), PARATASE (tradename of lipase manufactured by Novo Nordisk Ltd.) and tLIPASE D (trade name of lipase manufactured by AmanoSeiyaku K.K.), was dissolved in city water to preparean enzyme solution containing 10% by weight of theenzyme. Then, 30% by weight of jS -tocopherol and 10% byweight of LECITHIN DELUXE were mixed with the enzymesolution, and the mixed solution was kept stirred witha stirrer for 24 hours while maintaining the solutiontemperature at 4°C. A thermal stability test wasapplied to the mixed solution and to a control casewhere an oil-soluble vitamin was not added to theenzyme solution. Table 6 shows the results.Example 13:Strains of Bacillus subtilis ATCC-4529 werecultured for 36 hours at 30°C in a fermenting vesselhaving an inner volume of 50L by using culture medium 6given below under a stirring rotation speed of 300 rpmand 1 VVM. The culture solution was centrifuged at4,000 rpm for 10 minutes to obtain 23L of a supernatant.Then, 40% by weight based on the enzyme amount of BASISLP-20 and 30% by weight of ubiquinone were mixed withthe supernatant, and the mixture was kept stirred witha stirrer for 24 hours while cooling the mixture at 4°Cwith ice. The mixed solution was subjected to a spraydrying under the inlet temperature of 185^C and theoutlet temperature of 95cC to obtain 1350g of subtilisin(serine protease) powder. For measuring the enzymeactivity, 1 mL of the enzyme was added to 3 mL of 3 / 4%milk casein dissolved in 0.05M buffer solution having apH 11,0 for carrying out the reaction for 10 minutes at37°C. Then, the reaction was stopped by usingtrichloroacetic acid. The enzyme activity wascalculated by measuring the absorbance of 660 nm.Incidentally, the enzyme 1U represents the enzymeamount required for forming 1 fi mol of tyrosine ina minute. Table 7 shows the results.Example 14:Strains of Lactobacillus acidophilus IFO-1395 werecultured at 37°C for 48 hours in a fermenting vesselhaving an inner volume of SOL under a stirring rotationspeed of 300 rpm and 1 WM. The culture solution wascentrifuged at 4,000 rpm for one minute to obtain 22Lof a supernatant. Then, 30% by weight based on theenzyme weight of BASIS LG-2 0P (trade name of lecithinmanufactured by Nisshin Oil Mills).and 40% by weight ofphylloquinone were mixed with the supernatant, andthe mixture was kept stirred for 12 hours while coolingthe mixture to 4°C with ice. The mixed solution wassubjected to a spray drying at the inlet temperatureof 195°C and the outlet temperature of 98°C to obtain1.85 kg of j3-galactosidase powder. For measuring theenzyme activity, a substrate solution was prepared bydissolving 0.0025 M of o-nitrophenyl-l-galactoside in1 / 10 M phosphoric acid buffer solution having a pH 7.0.,Then, 1 mL of the enzyme solution was added to 4 mL ofthe substrate solution for carrying out the reaction at40°C for 10 minutes, followed by stopping the reactionusing sodium carbonate. The enzyme activity wascalculated by measuring the absorbance of 420 nm.The enzyme 1U represents an enzyme amount that permitsliberating 1 ji mol of o-nitrophenol in a minute.Table 8 shows the results.Table 1 Thermal stability of lipaseTable 2 Thermal stability dependent on difference in emulsifierTable 3 Comparison of thermal stability dependent on differencein phospholipid and oil-soluble vitaminEnzyme activity remaining rate0 minute 10 minutes 20 minutes 30 minutesExample 3 100 100 93 83Example 4 100 100 91 85Example 5 100 100 88 81Example 6 100 100 95 82Example 7 100 100 91 83Table 4 Comparison in thermal stability andactivity yield under each drying methodEnzyme activity remaining rate Heat recovery0 minute 10 minutes 20 minutes 30 minutes Rate (%)Example 8 100 95 88 76 75.8Comparative Example 6 100 98 92 83 72.9Comparative Example 7 100 99 88 74 33.9Table 5 Thermal stability for each manufacturing methodTable 6 Thermal stability test for enzymes available on the marketTable 7 Stability of proteaseEnzyme activity remaining rate 0 minute 10 minutes 20 minutes 30 minutesExample 13 concentrated enzyme solution Enzyme powder control (no addition) 100 100 100 93 100 100 99 95 100 82 72 55Table 8 Thermal stability of sugar-decomposing enzymeEnzyme activity remaining rate 0 minute 10 minutes 20 minutes 30 minutesExample 14 concentrated enzyme solution enzyme powder control (no addition) 100 100 95 83 101 100 100 89 100 81 75 51As described above, a phospholipid and an oil-soluble vitamin are added to an enzyme in the presentinvention. As a result, the thermal., stability of theenzyme in an aqueous system is markedly improved. Alsosince a sufficient enzyme activity at high temperaturescan be obtained in the enzyme reaction and the activityis stable, the enzyme synthesis can be performed byusing a substrate having a high melting point. Furthersince the enzyme solution can be concentrated andconverted into an enzyme powder under heat, the enzyme .powder can be prepared efficiently.Additional advantages and modifications willreadily occur to those skilled in the art. Therefore,the invention in its broader aspects is not limited tothe specific details and representative embodimentsshown and described herein. Accordingly, variousmodifications may be made without departing from thespirit or scope of the general inventive concept asdefined by the appended claims and their equivalents.

Claims

Claims I What is claimed is 1. A thermally stable enzyme composition, comprising an enzyme and . a heat * stabilizer comprising a phospholipid and an oil-soluble vitamin, said enzyme is selected from the group consisting of lipoprotein lipase, monoacyl glycerol lipase, diacyl glycerol * lipase, triacyl glycerol lipase, and galactolipase.

2. The composition according to claim 1, wherein said phospholipid is contained in * an amount of from 0.01 to 200% by weight and said oil-soluble vitamin is continued in an t * amount of from 0.01 to 100% by weight, based on the enzyme weight. j3. The composition according to claim 1, wherein said oil-soluble vitamin is at least ί one compound selected from the group consisting of tocopherol, tocotrienol, retinol, , calciferol, phylloquinone, and ubiquinone.

4. The composition according to claim 1, wherein said phospholipid is at least one ’ compound selected from the group consisting of phosphatidyl choline, phosphatidyl ’ I ethanol, phosphatidic acid, phosphatidyl inositol, phosphatidyl serine and lyso forms thereof.

15. The composition according to claim 1, which is in the form of a powder6. A thermally stable enzyme composition, comprising an enzyme and a heat' stabilizer comprising a phospholipid and an oil-soluble vitamin, said enzyme is a glycosylase selected from the group consisting of amylase, glucosidase, cellulase, xylanase, dextranase, chitinase, lysozyme, galactosidase,' mannosidase, glucOnidase, hyaluronidase, and pectinlyase. k I7. “ The composition according to claim 6, wherein said phospolipid is contained in an ' amount of from 0.01 to 200% by weight and said oil-soluble vitamin is continued in an^ amount of from 0.01 to 100% by weight, based on the enzyme weight. j8. The composition according to claim 6, wherein said oil-soluble vitamin is at least * one compound selected from the group consisting of tocopherol, tocotrienol, retinol, calciferol, phylloquinone, and ubiquinone. ; i9. The composition according to claim 6, wherein said phospholipid is at least one + compound selected from the group consisting of phosphatidyl choline, phosphatidyl j ethanol, phosphatidic acid, phosphatidyl inositol, phosphatidyl serine and lyso forms thereof.

10. The composition according to claim 6, which is in the form of a powder.

11. A thermally stable enzyme composition, comprising an enzyme and a heat stabilizer comprising a phospholipid and an oil-soluble vitamin, said enzyme is a protease , selected from the group consisting of acid proteinase, serine protease, cysteine protease, « dipeptidylamino peptidase, and dipeptidylcarboxy peptidase. ! I12. The composition according to claim 11, wherein Said phospholipid is contained in an amount of from 0.01 to 200% by weight and said oil-soluble vitamin is continued in an amount of from 0.01 to 100% by weight based on the enzyme weight. I I13. The composition according to claim 11, wherein said oil-soluble vitamin is at least one compound selected from the group consisting of tocopherol, tocotrienol, retinol, calciferol, phylloquinone, and ubiquinone. I14. The composition according to claim 11 wherein said phospholipid is at least one compound selected from the group consisting of phosphatidyl choline, phosphatidyl ethanol, phosphatidic acid, phosphatidyl inositol, phosphatidyl serine and lyso forms : thereof. [15. The composition according to claim 11, which is in the form of a powder.

16. A thermally stable enzyme composition, comprising an enzyme and a heat stabilizer comprising a phospholipid and an oil-soluble vitamin, said phospholipid being present in an amount of from 1 to 8% by weight based on the weight of the enzyme, said oil-soluble vitamin being present in an amount of from 0.01 to 20% by weight based on 5 the weight of the enzyme and wherein said enzyme is a lipase selected from the group consisting of lipoprotein lipase, monoacyl glycerol lipase, diacyl glycerol lipase, triacyl, glycerol lipase, and galactolipase.

17. The composition according to claim 16, wherein said oil-soluble vitamin is at least 10 one compound selected from the group consisting of tocopherol, tocotrienol, retinol, calciferol, phylloquinone and ubiquinone.

18. The composition according to claim 16, wherein said phospholipid is at least one selected from the group consisting of phosphatidyl choline, phosphatidyl ethanol, 15 phosphatidic acid, phosphatidyl inositol, phosphatidyl serine and lyso forms thereof.

19. The composition according to claim 16, which is in powder form.

20. A thermally stable enzyme composition, comprising an enzyme and a heat 20 stabilizer comprising a phospholipid and an oil-soluble vitamin, said phospholipid being present in an amount of from 1 to 8% by weight based on the weight of the enzyme, said oil-soluble vitamin being present in an amount of from 0.01 to 20% by weight based on the weight of the enzyme and wherein said enzyme is a glycosylase selected from the group consisting of amylase, glucosidase, cellulase, xylanase, dextranase, chitinase, 25 lysozyme, galactosidase, mannosidase, gluconidase, hyaluronidase, and pectin lyase.

21. The composition according to claim 20, wherein said oil-soluble vitamin is at least one compound selected from the group consisting of tocopherol, tocotrienol, retinol, calciferol, phylloquinone and ubiquinone. ε > ;22. The composition according to claim 20, wherein said phospholipid is at least one selected from the group consisting of phosphatidyl choline, phosphatidyl ethanol, phosphatidic acid, phosphatidyl inositol, phosphatidyl serine and lyso forms thereof. η 523. The composition according to claim 20, which is in powder form. *24. A thermally stable enzyme composition, comprising an enzyme and a heat μ stabilizer comprising a phospholipid and an oil-soluble vitamin, said phospholipid being : . I present in an amount of from 1 to 8% by weight based on the weight of the enzyme, said ! 10 oil-soluble vitamin being present in an amount of from 0.01 to 20% by weight based on . the weight of the enzyme and wherein said enzyme, is a protease selected from the group of acid proteinase, serine protease, cysteine protease, and dipeptidylcarboxy peptidase. .

25. The composition according to claim 24, wherein said oil-soluble vitamin is at least j 15 one compound selected from the group consisting of tocopherol, tocotrienol, retinol, j calciferol, phylloquinone, and ubiquinone.

126. The composition according to claim 24, wherein said phospholipid is at least one selected from the group consisting of phosphatidyl choline, phosphatidyl ethanol, J 20 phosphatidic acid, phosphatidyl inositol, phosphatidyl serine and lyso forms thereof. I27. The composition according to claim 24, which is in powder form.